LRP6 in mesenchymal stem cells is required for bone formation during bone growth and bone remodeling

Bone Research

Volumn 2, Issue , 2014, Pages

  Li, Changjun ^a   Williams, Bart O ^b   Cao, Xu ^a   Wan, Mei ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85006298691     PISSN: 20954700     EISSN: 20956231     Source Type: Journal    
DOI: 10.1038/boneres.2014.6     Document Type: Article

References (45)

1. Tamai K, Semenov M, Kato Y et al. LDL-receptor-related proteins inWnt signal transduction. Nature 2000; 407: 530-535.
2. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC. An LDLreceptor-related protein mediates Wnt signalling in mice. Nature 2000; 407: 535-538.
3. Huelsken J, Birchmeier W. New aspects of Wnt signaling pathways in higher vertebrates. Curr Opin Genet Dev 2001; 11: 547-553.
4. Mao J, Wang J, Liu B et al. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell 2001; 7: 801-809.
5. Tamai K, Zeng X, Liu C et al. Amechanismfor Wnt coreceptor activation. Mol Cell 2004; 13: 149-156.
6. Mani A, Radhakrishnan J, Wang H et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 2007; 315: 1278-1282.
7. Singh R, Smith E, Fathzadeh M et al. Rare nonconservative LRP6 mutations are associated with metabolic syndrome. Hum Mutat 2013; 34: 1221-1225.
8. van Meurs JB, Rivadeneira F, JhamaiMet al. Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J Bone Miner Res 2006; 21: 141-150.
9. van Meurs JB, Trikalinos TA, Ralston SH et al. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA 2008; 299: 1277-1290.
10. Kelly OG, Pinson KI, Skarnes WC. The Wnt co-receptors Lrp5 and Lrp6 are essential for gastrulation in mice. Development 2004; 131: 2803-2815.
11. Holmen SL,Giambernardi TA, Zylstra CR et al. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J Bone Miner Res 2004; 19: 2033-2040.
12. Li C, Xing Q, Yu B et al. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH. J Bone Miner Res 2013; 28: 2094-2108.
13. Riddle RC, Diegel CR, Leslie JM et al. Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition. PLoS ONE 2013; 8: e63323.
14. Gong Y, Slee RB, Fukai N et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001; 107: 513-523.
15. Little RD, Recker RR, Johnson ML. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 2002; 347: 943-944.
16. Little RD, Carulli JP, del Mastro RG et al. A mutation in the LDL receptorrelated protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 2002; 70: 11-19.
17. Boyden LM, Mao J, Belsky J et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 2002; 346: 1513-1521.
18. Kokubu C, Heinzmann U, Kokubu T et al. Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis. Development 2004; 131: 5469-5480.
19. Kubota T, Michigami T, Sakaguchi N et al. Lrp6 hypomorphic mutation affects bone mass through bone resorption in mice and impairs interaction with Mesd. J Bone Miner Res 2008; 23: 1661-1671.
20. Park D, Spencer JA, Koh BI et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell 2012; 10: 259-272.
21. Joeng KS, Schumacher CA, Zylstra-Diegel CR, Long F, Williams BO. Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo. Dev Biol 2011; 359: 222-229.
22. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990; 60: 585-595.
23. Mendez-Ferrer S, Michurina TV, Ferraro F et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829-834.
24. Zylstra CR, Wan C, VanKoevering KK et al. Gene targeting approaches in mice: assessing the roles of LRP5 and LRP6 in osteoblasts. JMusculoskelet Neuron Interact 2008; 8: 291-293.
25. Wu X, Pang L, Lei W et al. Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell 2010; 7: 571-580.
26. Zhang M, Xuan S, Bouxsein ML et al. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 2002; 277: 44005-44012.
27. Canalis E, Parker K, Feng JQ, Zanotti S. Osteoblast lineage-specific effects of notch activation in the skeleton. Endocrinology 2013; 154: 623-634.
28. Courtland HW, Elis S, Wu Y et al. Serum IGF-1 affects skeletal acquisition in a temporal and compartment-specific manner. PLoS ONE 2011; 6: e14762.
29. Wan M, Yang C, Li J et al. Parathyroid hormone signaling through lowdensity lipoprotein-related protein 6. Genes Dev 2008; 22: 2968-2979.
30. WanM, Li J,HerbstKet al. LRP6 mediatescAMPgeneration byGproteincoupled receptors through regulating the membrane targeting of Galpha(s). Sci Signal 2011; 4: ra15.
31. Shi C, Li J,WangW, Cao W, Cao X,Wan M. Antagonists of LRP6 regulate PTH-induced cAMP generation. Ann NY Acad Sci 2011; 1237: 39-46.
32. Yu B, Zhao X, Yang C et al. Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling. J Bone Miner Res 2012; 27: 2001-2014.
33. Ren S, Johnson BG, Kida Y et al. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Proc Natl Acad Sci USA 2013; 110: 1440-1445.
34. Semenov MV, Tamai K, Brott BK, Kuhl M, Sokol S, He X. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 2001; 11: 951-961.
35. Mao B, Wu W, Li Y et al. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 2001; 411: 321-325.
36. Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol 2001; 3: 683-686.
37. Semenov M, Tamai K, He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem 2005; 280: 26770-26775.
38. Semenov MV, He X. LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J Biol Chem 2006; 281: 38276-38284.
39. Li X, Zhang Y, Kang H et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 2005; 280: 19883-19887.
40. Ellies DL, Viviano B, McCarthy J et al. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Miner Res 2006; 21: 1738-1749.
41. Bonaguidi MA, Wheeler MA, Shapiro JS et al. In vivo clonal analysis reveals self-renewing and multipotent adult neural stem cell characteristics. Cell 2011; 145: 1142-1155.
42. Burns KA, Ayoub AE, Breunig JJ et al. Nestin-CreER mice reveal DNA synthesis by nonapoptotic neurons following cerebral ischemia hypoxia. Cereb Cortex 2007; 17: 2585-2592.
43. Burns KA, Murphy B, Danzer SC, Kuan CY. Developmental and postinjury cortical gliogenesis: a genetic fate-mapping study with Nestin-CreER mice. Glia 2009; 57: 1115-1129.
44. Castelo-Branco G, Andersson ER, Minina E et al. Delayed dopaminergic neuron differentiation in Lrp6 mutant mice. Dev Dyn 2010; 239: 211-221.
45. de Ferrari GV, Papassotiropoulos A, Biechele T et al. Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease. Proc Natl Acad Sci USA 2007; 104: 9434-9439.